Transpharmation

Transpharmation is a preclinical neuroscience contract research organisation providing translational pharmacology services to pharmaceutical and biotechnology companies.

The company's therapeutic expertise spans EEG, cognition, epilepsy, pain, neurodegeneration and mood disorders including treatment-resistant depression and schizophrenia, using validated behavioural and molecular assays to benchmark compounds against clinical standards.

Transpharmation operates laboratories at Discovery Park, Kent, and London, and recently combined with a Canadian neuroscience CRO to form one of the largest specialist providers in the field.